About this trial
This study aims to compare the efficacy of different doses of glucocorticoids in local infiltration analgesia (LIA) during total knee arthroplasty (TKA) through a prospective single-center randomized controlled trial, and to explore the safety and feasibility of high-dose glucocorticoids. Through this research, the investigators hope to provide an optimized solution for post-TKA pain management, improve patients' postoperative recovery and quality of life, and offer scientific evidence for pain management following TKA.
Eligibility criteria
Qualifiers
Male or female participants aged 18 years or older;
Undergoing primary unilateral total knee arthroplasty (TKA)for unilateral knee osteoarthritis(OA)at ourhospital;
Preoperative American Society of Anesthesiologists(ASA)physical status classification of 1-3;
Ability to provide informed consent and sign a written informed consent form.
Disqualifiers
Previous surgery on the operative knee or a history of infection in the operative knee;
Non-osteoarthritis conditions (including rheumatoid arthritis, traumatic arthritis, septic arthritis, and hemophilic arthritis);
Severe osteoarthritis (including flexion contracture >30° or varus/valgus deformity >30°);
Allergy to the relevant study drugs;
Trial design
Treatments tested in this trial
- LIA with different doses of Diprospan